Dr Reddy

Equities trade lower, Nifty around 11,900

Equities trade lower, Nifty around 11,900

Mumbai: Equity benchmark indices were in the negative zone during early hours on Wednesday as investors awaited fourth-quarter GDP data d...Read More

Dr Reddy’s Lab acquires Kolkata-based NBFC

Dr Reddy’s Lab acquires Kolkata-based NBFC

New Delhi: Dr Reddy’s Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-...Read More

placeholder

FIPB to take up 24 foreign investment proposals on Feb 21

New Delhi : FIPB will decide on 24 foreign investment proposals, including those of Vodafone India and Dr Reddy’s Laboratories, on Februa...Read More

Mahindra Ecole Centrale (MEC) hosts TEDx Conference

Mahindra Ecole Centrale (MEC) hosts TEDx Conference

Mahindra Ecole Centrale (MEC), an Indo-French engineering college, hosted TEDx Conference at the campus in Hyderabad. This TEDx Conferenc...Read More

Dr Reddy’s acquires  8 ANDAs in US from Teva Pharma for $350 mn

Dr Reddy’s acquires 8 ANDAs in US from Teva Pharma for $350 mn

Mumbai : Dr Reddy’s Laboratories Ltd has signed an agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan Plc to ...Read More

placeholder

Dr Reddy’s faces US body’s ire

Hyderabad: The US Consumer Product Safety Commission has approached the US Department of Justice seeking action against Dr Reddy’s Labora...Read More

placeholder

Dr Reddy’s Labs board OKs share buyback at Rs 3,500/share

New Delhi : Drug major Dr Reddy’s Laboratories Ltd  will buyback around 44.85 lakh shares, accounting for about 2.6% of the existing paid...Read More

Dr Reddy’s gets USFDA nod for migraine injection

Dr Reddy’s gets USFDA nod for migraine injection

New Delhi: Drug major Dr Reddy’s Laboratories (DRL) has received US health regulator’s approval to market ZembraceSymTouch injection, a d...Read More

Dr Reddy’s slumps 9%, analysts see US FDA issues resolution taking up to 3 yrs

Dr Reddy’s slumps 9%, analysts see US FDA issues resolution taking up to 3 yrs

US FDA’s action may lead to no new active pharma ingredients approvals from the sites under regulatory lens, which may slow down the comp...Read More

placeholder

US FDA warns Dr Reddy’s of import ban if flaws are not fixed

Hyderabad : The US Food and Drug Administration (US FDA), which had issued a warning letter to Dr Reddy’s Laboratories over quality issue...Read More

placeholder

Dr Reddy’s countersues AstraZeneca

Hyderabad:  Dr Reddy’s Laboratories, which is embroiled in a legal battle with AstraZeneca over the usage of purple colour for generic ve...Read More

placeholder

US court asks DRL to temporarily stop sale of Nexium generic

AstraZeneca had moved the court objecting to use of purple colour by Dr Reddy’s in its generic of Nexium

Dr Reddy’s gets US FDA warning on 3 units, stock tanks 15%

Dr Reddy’s gets US FDA warning on 3 units, stock tanks 15%

The warning letters have been issued for violation of good manufacturing norms at Srikakulam and Miryalaguda plants in Telangana and onco...Read More

placeholder

Import alert fears to continue to weigh on stock in near term

MUMBAI : With Ranbaxy Laboratories Ltd’s troubles with the US regulator still fresh in the minds of investors, analysts expect sentiment ...Read More

Sensex down for 5th day, slips 181 pts to trade near 1-mth low

Sensex down for 5th day, slips 181 pts to trade near 1-mth low

Mumbai: The domestic stock market extended loses to a fifth straight session today as the benchmark BSE Sensex slipped by 181 points to f...Read More

placeholder

Dr Reddy’s teams up with Purdue University for drug research

Hyderabad : The US-based Purdue University has signed a MoU with Dr Reddy’s Laboratories Limited (DRL) to forge a strong strategic partne...Read More

placeholder

Dr Reddy’s to acquire UCB’s select brands for Rs 800 cr

New Delhi : Drug firm Dr Reddy’s Laboratories will acquire select portfolio of established brands of Belgian firm UCB in India, Nepal, Sr...Read More

placeholder

Dr Reddy’s To Launch Generic Version Of Valcyte In US Mkt

Hyderabad : Shares of Dr Reddy’s Laboratories rose by over 4% on Friday, adding Rs 2,476.87 crore to its market capitalisation, after the...Read More

Free Press Journal

www.freepressjournal.in